Arkolith/Insider Trading/OVID/Form 4

Takeda Pharmaceuticals U.S.A., Inc.

10% OwnerOvid Therapeutics Inc. (OVID) · full profile →Form 4 · filed Dec 9, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2025Conversion(C)1.3M—$07.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 8, 2025Conversion(C)1K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001395064-25-000172) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML